BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18544275)

  • 1. The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B.
    Wei XQ; Guo YW; Liu JJ; Wen ZF; Yang SJ; Yao JL
    Clin Invest Med; 2008; 31(3):E123-30. PubMed ID: 18544275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2.15 via Toll-like receptor 4].
    Hou HR; Kang Y; Li YK; Zeng YL; Wei JF; Ding GG; Peng Z; Shang J
    Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):908-913. PubMed ID: 29325291
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
    Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
    Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A close relationship between viral hepatitis B and Toll-like receptor 2].
    Guo YW; Wei XQ; Yang SJ
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):485-8. PubMed ID: 17669234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
    Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
    BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein.
    Visvanathan K; Skinner NA; Thompson AJ; Riordan SM; Sozzi V; Edwards R; Rodgers S; Kurtovic J; Chang J; Lewin S; Desmond P; Locarnini S
    Hepatology; 2007 Jan; 45(1):102-10. PubMed ID: 17187404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of CD14 and TLR4 expressions in severe hepatitis B induced by endotoxin].
    Cheng XY; Zhang LL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):428-32. PubMed ID: 20587312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of toll-like receptor 4 on T cells in PBMCs is associated with disease aggravation of HBV-related acute-on-chronic liver failure.
    Xu CL; Hao YH; Lu YP; Tang ZS; Yang XC; Wu J; Zheng X; Wang BJ; Liu J; Yang DL
    J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):910-915. PubMed ID: 26670445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.
    Yin Y; Li F; Li S; Cai J; Shi J; Jiang Y
    Cell Physiol Biochem; 2017; 42(2):469-479. PubMed ID: 28578348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells.
    Huang C; Zhang H; Bai R; Wang L; Lv J
    DNA Cell Biol; 2017 Nov; 36(11):1029-1038. PubMed ID: 28945461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence.
    Soares JB; Pimentel-Nunes P; Afonso L; Rolanda C; Lopes P; Roncon-Albuquerque R; Gonçalves N; Boal-Carvalho I; Pardal F; Lopes S; Macedo G; Lara-Santos L; Henrique R; Moreira-Dias L; Gonçalves R; Dinis-Ribeiro M; Leite-Moreira AF
    Innate Immun; 2012 Oct; 18(5):700-8. PubMed ID: 22330637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
    Hsiao CC; Kao YH; Huang SC; Chuang JH
    Pediatr Blood Cancer; 2013 Feb; 60(2):248-53. PubMed ID: 22648929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the Iron Homeostasis Network of Hepatocytes Caused by Hepatitis B Virus.
    Hou SW; Wang ZF; Guan SH; Yang K; Wang Q; Chen LW; Zhang H; Wang X; Duan YL; Pan ZL
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
    Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
    Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-viral role of toll like receptor 4 in hepatitis B virus infection: An
    Das D; Sarkar N; Sengupta I; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakravarty R
    World J Gastroenterol; 2016 Dec; 22(47):10341-10352. PubMed ID: 28058014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expressions and significance of TLR2 and TLR4 in Kupffer cells of tree shrews chronically infected with hepatitis B virus].
    Ruan P; Yang C; Su J; Ou C; Cao J; Luo C; Tang Y; Qin H; Sun W; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):686-90. PubMed ID: 25001929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2.
    Cheng S; Zhang B; Du JY; Jin YH; Lang HY; Zeng LH
    Viral Immunol; 2017 Apr; 30(3):232-239. PubMed ID: 28061318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
    Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
    J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
    Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
    Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.